US Appellate Court boosts ‘diagnose and treat’ claims

By Amos B, Macedo C, Miller A.

Abstract

Vanda Pharmaceuticals Inc v West-Ward Pharmaceuticals, US Court of Appeals for the Federal Circuit, 126 USPQ2d 1266 (2018), 13 April 2018The US Court of Appeals for the Federal Circuit clarified that, at least in special circumstances, a ‘diagnose and treat’ claim is both patent-eligible and enforceable. …read more

Source:: Journal of Intellectual Property Law & Practice